Search Within

Genitourinary Oncology Service

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (149)
  2. Meeting Abstract (116)
  3. Review (7)
  4. Correspondence (3)
  5. Book Section (2)
  6. Conference Paper (1)
  7. Guidelines (1)
  8. Research Letter (1)
Groups
  1. Department of Medicine (280)
  2. Molecular Imaging and Therapy Service (280)
  3. Solid Tumor Oncology Division (280)
  4. Radiology, Department of (249)
  5. GSK Faculty (204)
  6. Sloan Kettering Institute Faculty (166)

More Groups

People
  1. Steven Larson (151)
  2. Michael Morris (142)
  3. Howard Scher (141)
  4. Neeta Pandit-Taskar (53)
  5. David Solit (44)
  6. Hebert Vargas Alvarez (41)

More People

Years
  1. 2025 (10)
  2. 2024 (9)
  3. 2023 (16)
  4. 2022 (13)
  5. 2021 (16)
  6. 2020 (16)

More Years

Publications
  1. Journal of Clinical Oncology (89)
  2. Journal of Nuclear Medicine (45)
  3. Clinical Cancer Research (26)
  4. Cancer Research (10)
  5. Annals of Oncology (5)
  6. Journal of Urology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (92)
  2. Society of Nuclear Medicine (45)
  3. American Association for Cancer Research (42)
  4. Springer (15)
  5. Elsevier Science, Inc. (13)
  6. Elsevier Inc. (12)

More Publishers

Results (280)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CONVERGE-01: Dosimetry, randomized dose optimization, dose escalation and efficacy of Ac-225 rosopatamab tetraxetan in participants with PSMA-positive castration-resistant prostate cancer
    Meeting Abstract

    Pandit-taskar, N.; Morris, M.; Kiess, A.; Nordquist, L.; Gupta, S.; George, D.; Antonarakis, E.; Messmann, R.; Kantoff, P.; Vallabhajosula, S.; more...
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • Clinical utility and prognostic implications of circulating cell-free DNA in biliary tract cancer
    Journal Article

    Cowzer, D.; Darmofal, M.; Seier, K.; Thummalapalli, R.; Walch, H.; El Dika, I.; Khalil, D. N.; Park, W.; Dhyani, A.; Yaqubie, A.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Two decades of disease evolution and biomarker-guided clinical decision making in metastatic prostate cancer
    Journal Article

    Erazo, T.; Moiso, E.; Aras, O.; Scher, H. I.
    International Journal of Molecular Sciences (2025)

    Fulltext@MSK | Save
  • Symptomatic prostate-specific membrane antigen PET–positive radionecrosis after multimodality brain metastasis–directed treatment including [(177)Lu]Lu-PSMA-617
    Journal Article

    Imber, B. S.; Yu, K. K. H.; Abida, W.; Pike, L. R. G.; Grkovski, M.; Kaley, T. J.; Morris, M. J.; Bodei, L.; Nosov, A.; Dunphy, M. P. S.; more...
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • Post-transplant pain and paralysis: Neurologic amyotrophy as an atypical cause of shoulder dysfunction following hematopoietic stem cell transplant
    Journal Article

    König, F.; Davidoff, C.; Ibanez, K.; Hwang, S.; Goldstein, I.; Feldman, D. R.; Gyurkocza, B.; Giralt, S. A.; Politikos, I.; Ponce, D. M.; more...
    Cancers (2025)

    Fulltext@MSK | Save
  • STARLITE 2: Phase 2 study of nivolumab plus (177)lutetium-labeled anti-carbonic anhydrase IX (CAIX) monoclonal antibody girentuximab ((177)Lu-girentuximab) in patients with advanced clear cell renal cell carcinoma (ccRCC)
    Meeting Abstract

    Feldman, D. R.; Motzer, R. J.; Knezevic, A.; Voss, M. H.; Lyashchenko, S. K.; Park, H.; Larson, S. M.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A novel predictive model using changes in clinical and serum biomarkers and automated quantitative imaging for mCRPC patients treated with AR-directed therapy
    Meeting Abstract

    Morris, M. J.; Flynn, J.; Zhao, B.; Anand, A.; Sjöstrand, K.; Larson, S. M.; Scher, H. I.; Regazzi, A. M.; Borzillo, G. V.; Park, A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Updated long-term follow-up from a phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma
    Meeting Abstract

    Jayalath, V.; Teo, M. Y.; Assel, M.; Rodriguez, D.; Meyerson, A.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Cha, E. K.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Clinical, imaging, and technical factors associated with successful genomic profiling of bone biopsy tissue in prostate cancer
    Journal Article

    Ridouani, F.; Vargas, H. A.; Holzwanger, D. J.; Schöder, H.; Waters, E.; Petre, E. N.; Martin, A.; Satagopan, J.; Gonen, M.; Autio, K. A.; more...
    European Urology Oncology (2025)

    Fulltext@MSK | Save
  • Molecular and clinical determinants of targeted therapy (TT) outcomes in biliary tract cancer (BTC): Analysis of a prospectively maintained next generation sequencing (NGS) biorepository
    Meeting Abstract

    Cowzer, D.; Walch, H. S.; Atri, P.; Shah, F.; Huq, R.; Khalil, D. N.; Park, W.; Yeh, R.; Do, R. K. G.; Basturk, O.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save